Konstantinos Xynos

Chief Tech/Sci/R&D Officer at REPLIMUNE GROUP, INC.

Net worth: 3 M $ as of 2026-07-30

60 year

Consumer Services

Health Technology

Profile

Konstantinos Xynos is Chief Medical Officer at Replimune Group, Inc. since 2022.
Formerly, Dr. Xynos was Vice President & Head-Global Medical Affairs at Deciphera Pharmaceuticals, Inc. from 2019 to 2021.
Education includes an undergraduate degree from the University of Illinois (1991), a doctorate from Aristotle University of Thessaloniki (1997), a doctorate from National & Kapodistrian University of Athens (2012), and an MBA from the University of Strathclyde (2013).

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
REPLIMUNE GROUP, INC. 0.29%	2026-08-09	224,215 ( 0.29% )	3 M $	2026-07-30

Konstantinos Xynos active positions

Companies	Position	Start
REPLIMUNE GROUP, INC.	Chief Tech/Sci/R&D Officer	2022-11-30

All active positions of Konstantinos Xynos

Former positions of Konstantinos Xynos

Companies	Position	End
DECIPHERA PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	2020-12-31

See the detail of Konstantinos Xynos's experience

Training of Konstantinos Xynos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Konstantinos Xynos's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Strathclyde University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aristotle University of Thessaloniki Aristotle University of Thessaloniki Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
National & Kapodistrian University of Athens National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Replimune Group, Inc. Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies	Health Technology
Deciphera Pharmaceuticals, Inc. Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients	Health Technology